Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03428464 · ClinicalTrials.gov registry record · NA
Bicarbonate Administration in Kidney Transplant Recipients
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03428464 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT03428464, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Metabolic acidosis is associated with vascular endothelial dysfunction and is a common complication in patients who have received a kidney transplant. Kidney transplant recipients (KTR) with lower serum bicarbonate levels, even within the normal range, have an increased risk of graft loss and mortality. The investigators propose a prospective, double-blind, randomized, placebo-controlled, 18-week crossover pilot study to examine the effects of sodium bicarbonate on vascular endothelial function, graft function, and cognitive function in 20 KTR patients.
Interventions
- OTHER Placebo
- DRUG Sodium Bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03428464
The ClinicalTrials.gov registry entry for NCT03428464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03428464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03428464 about?
NCT03428464 is a clinical study titled "Bicarbonate Administration in Kidney Transplant Recipients". Metabolic acidosis is associated with vascular endothelial dysfunction and is a common complication in patients who have received a kidney transplant. Kidney transplant recipients (KTR) with lower serum bicarbonate levels, even within the normal range, have an increased risk of graft loss and mortal...
What is the current status of trial NCT03428464?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-05. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT03428464?
The interventions under investigation include: Placebo (OTHER), Sodium Bicarbonate (DRUG).
Who is sponsoring clinical trial NCT03428464?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.